Ghost Tree Capital’s Kura Oncology KURA Stock Holding History

Ghost Tree Capital’s Portfolio KURA Stock Details KURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-225,000	Closed	-$3.15M	–	50
2021 Q4	$3.15M	Sell	225,000 -200,000	-47%	-$3.24M	1.13%	35
2021 Q3	$7.96M	Sell	425,000 -275,000	-39%	-$5.18M	2.33%	14
2021 Q2	$14.6M	Buy	700,000 +100,000	+17%	+$2.48M	4.01%	8
2021 Q1	$17M	Buy	600,000 +275,000	+85%	+$8.7M	3.99%	6
2020 Q4	$10.6M	Buy	325,000 +100,000	+44%	+$3.51M	2.37%	20
2020 Q3	$6.89M	Buy	+225,000	New	+$4.97M	1.99%	17
2018 Q4	–	Sell	-230,000	Closed	-$4.03M	–	52
2018 Q3	$4.03M	Hold	230,000	–	–	0.86%	34
2018 Q2	$4.19M	Buy	+230,000	New	+$3.9M	1.23%	28

Other funds holding KURA

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

AWA

Aaron Wealth Advisors Chicago, Illinois $1.97B AUM 36.91% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Ghost Tree Capital's KURA Position: Q1 2022 in Review

Ghost Tree Capital sold out of Kura Oncology (KURA) in Q1 2022, closing a stake of 225,000 shares — an estimated $3.15M sold.

Ghost Tree Capital first reported a position in KURA in Q2 2018 and held it in 8 quarters. The position peaked at $17M in Q1 2021. 152 funds tracked by Wall St. Rank hold KURA as of Q1 2022.

Ghost Tree Capital reported no remaining Kura Oncology position as of Q1 2022 after selling out during the quarter.
Ghost Tree Capital sold 225,000 Kura Oncology shares in Q1 2022, an estimated $3.15M.
Ghost Tree Capital first reported a position in Kura Oncology in Q2 2018 and held it in 8 quarters.
Ghost Tree Capital's Kura Oncology position peaked at $17M in Q1 2021.
152 funds tracked by Wall St. Rank held Kura Oncology as of Q1 2022.

Based on Ghost Tree Capital's 13F filing for Q1 2022, filed 16 May 2022.